Waste

Prevention Strategies

FDA Recommendation to Transition to Duodenoscopes with Innovative Designs Poses Challenges

Such contamination lingers because cleaning duodenoscopes is notoriously complex.

In 2015, in response to a series of infection outbreaks linked to contaminated duodenoscopes, the Food and Drug Administration (FDA) ordered manufacturers to conduct post-market surveillance studies on their instruments. Preliminary results released as of March 2019 found post-reprocessing contamination rates to be higher than expected—the study assumed less than a 0.4 percent contamination rate but 3.6 percent to 5.4 percent of samples tested positive for organisms.

This discovery comes as the agency has recommended major shifts in gastroenterological care. Among other changes, the agency has requested that providers who perform endoscopic retrograde cholangiopancreatography (ERCP) transition away from fixed endcap duodenoscopes and move to using duodenoscopes with disposable components.

Such a transition, however, poses considerable challenges. How can providers, manufacturers, and infection prevention departments implement this shift without undue strain on their limited time and resources?

This series of posts will guide stakeholders through the process, exploring the rationale behind the FDA’s decision and outlining the major obstacles as transition plans are designed and put into action.

Duodenoscope contamination poses a risk to patient safety, though the risk of infection is relatively small. Since 2015, under the FDA’s direction, Olympus Medical Systems, Pentax of America, and Fujifilm Medical Systems have conducted post-market surveillance studies on samplings of their duodenoscopes. The studies found that, between all three manufacturers’ products, roughly 9 percent of the examined scopes showed signs of contamination, including 5.4 percent from high-concern organisms, such as E. coli and Pseudomonas aeruginosa.

Such contamination lingers because cleaning duodenoscopes is notoriously complex. The instruments can’t be exposed to high-heat sterilization, and technicians often struggle to manually clean their narrow tubing and elaborate moving parts.

Not only is the chance of infection small, ERCP is a vital procedure for patients with pancreatic disease. Each year more than half a million Americans depend on it. Alternatives to ERCP are both scarce and invasive—riskier for patients.

That is why the FDA has called for providers, manufacturers, and infection-prevention experts to reevaluate their approach to reprocessing. Possible steps include simplifying reprocessing procedures, finding novel approaches to cleaning and disinfection, and, eventually, using duodenoscopes with disposable components.

Read more:

More Intensive Care Articles
Can Robotic Bronchoscopy Improve Diagnostic and Surgical Procedures?
Bronchoscopy Procedure
Two sets of findings, recently presented at the annual CHEST conference, generated results that warrant further evaluation in studies designed to yield comparative trials in advanced bronchoscopic techniques, researchers say.
Study: Sterile Single-Use Bronchoscopes Less Costly than Reusable Bronchoscopes
Supply Costs
New research quantifies how much more hospitals pay to disinfect and reuse bronchoscopes rather than purchasing single-use instruments and builds on a study last year examining the effectiveness of cleaning processes used for reusable bronchoscopes.
More From Single-Use Endoscopy
Bronchoscopy

Public Health

AABIP recommends that physicians not perform bronchoscopies on patients despite upper respiratory sampling being a primary method of diagnosing the novel virus. However, if it's warranted physicians should use a disposable bronchoscope to protect patients and staff.

Waste

Prevention Strategies

How can providers, manufacturers, and infection-prevention departments implement this shift without undue strain on their limited time and resources? We explore this issue in a series of posts guiding stakeholders through the process.

Doctor Holding Duodenoscope

Prevention Strategies

The FDA’s move to spur innovative designs to boost patient safety has stoked the market’s appetite for disposable scopes, but there are development hurdles.